Navigation Links
Alseres Pharmaceuticals, Inc. to Present at Windhover's Therapeutic Area Partnerships Conference
Date:10/18/2007

HOPKINTON, Mass., Oct. 18 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) today announced that Dr. Frank Bobe, Executive Vice President and Chief Business Officer of Alseres Pharmaceuticals, Inc., will be presenting at Windhover Information's 2nd Annual Therapeutic Area Partnerships in Philadelphia, PA October 24-26, 2007. Dr. Bobe will be presenting an overview on Alseres Regenerative Therapeutics program. Cethrin(R), the Company's lead regenerative therapeutic for acute spinal cord injury, was named one of the "Top 10 Licensable Neuroscience Projects" by Windhover.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO )

Windhover Information's 2nd Annual Therapeutic Area Partnerships is the industry's most targeted and efficient partnering meeting for life science companies seeking partnerships in the top therapeutic areas: Oncology, Cardiovascular/Metabolic and Neuroscience. Decision-makers (business development and R & D) focusing on these therapeutic categories can meet to develop strategic alliances between their companies. For more information on the conference and speaking companies please go to http://www.tapartnerships.com .

About Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) is a biotechnology company engaged in developing breakthrough regener
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...tion of esophagus eliminated in 90 percent ...if., May 15 /- BARRX Medical, Inc., t...ous conditions of the,digestive tract, today annou...center U.S. study were free of the highest-risk of...endoscopic treatment using the,HALO360 ablation sy...
(Date:5/15/2008)...re-FirstCall/ -- Escalon Medical Corp.,(Nasdaq: E... quarter and,nine months ended March 31, 2008., F...ue increased 18% to,$8,139,000 compared with $6,90.... Product revenues were driven by increased sales ...enue for the third quarter of fiscal 2008 totaled ...
(Date:5/15/2008)...swire-FirstCall/ -- Bioheart, Inc. (Nasdaq:,BHRT) ...elopment of,autologous (patient-derived) cell ther... acute heart damage, today announced financial res...ancial Highlights, -- On February 19, 2008, the C...IPO) of common stock for gross proceeds of approxi...
(Date:5/15/2008)...e Advisory Panel reacts to CMS final rule; ..., MUNDELEIN, Ill., May 15 /- Medline...nd Care Advisory Panel announce the panel,s,first-... Improve Pressure,Ulcer Prevention and Treatment: ...esent on Admission (POA) Indicators/Hospital-Acqui...
Breaking Biology Technology:New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus 2New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus 3Escalon(R) Reports Third Quarter Fiscal 2008 Results 2Escalon(R) Reports Third Quarter Fiscal 2008 Results 3Escalon(R) Reports Third Quarter Fiscal 2008 Results 4Escalon(R) Reports Third Quarter Fiscal 2008 Results 5Escalon(R) Reports Third Quarter Fiscal 2008 Results 6Escalon(R) Reports Third Quarter Fiscal 2008 Results 7Escalon(R) Reports Third Quarter Fiscal 2008 Results 8Bioheart, Inc. Announces Financial Results for First Quarter 2008 2Bioheart, Inc. Announces Financial Results for First Quarter 2008 3Bioheart, Inc. Announces Financial Results for First Quarter 2008 4Bioheart, Inc. Announces Financial Results for First Quarter 2008 5Bioheart, Inc. Announces Financial Results for First Quarter 2008 6Bioheart, Inc. Announces Financial Results for First Quarter 2008 7International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper 2International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper 3
... Madison, Wis. - Be very afraid when a member ...m the U.S. patent system is that no one else in th...n America-bashing is back in vogue, there are cert... done well - much to the consternation of our riva...s is innovation. In fact, the United States is the...
... Madison, Wis. - The Wisconsin Alumni Research ...ments with two prominent technology companies, all...ia and tissue culture services used in embryonic s... were not disclosed. , ,The agreements mark the be...wo companies, Becton Dickinson & Co. , a medical ...
... Madison, Wis. - NimbleGen Systems , a manufact...ll discontinue its work toward an initial public o...he , the Basel, Switzerland based pharmaceutical g... in the IPO, but under the terms of a definitive a...l acquire 100 percent of the privately held Nimble...
... Almost a year ago, I did a brief summary of T...led It,s a Flat World After All and its impact on ...y visit to India this year, Friedman,s thoughts br...ce begun to read another book that has given me fu...ral, but specifically for the world of Big Pharma ...
Other Biology Technology:Changes to U.S. patent law must nurture our culture of innovation 2Changes to U.S. patent law must nurture our culture of innovation 3Changes to U.S. patent law must nurture our culture of innovation 4NimbleGen to discontinue IPO after Roche's $272.5 million acquisition 2NimbleGen to discontinue IPO after Roche's $272.5 million acquisition 3NimbleGen to discontinue IPO after Roche's $272.5 million acquisition 4The Right Brain: A neurological solution to the flattening world 2The Right Brain: A neurological solution to the flattening world 3The Right Brain: A neurological solution to the flattening world 4The Right Brain: A neurological solution to the flattening world 5
(Date:5/15/2008)...ATTLE Evolution is supposed to inch forward over ...tle fish called the threespine stickleback, the pr...ding to a study led by researchers at Fred Hutchin...ead of print in the May 20 issue of Current Biolog...xamples of reverse evolution in nature, said senio...
(Date:5/15/2008)..., The human race was divided into two separate g...stence, says a Tel Aviv University mathematician. ... conditions may have caused and maintained the sep...of Mathematical Sciences at Tel Aviv University, w... Medical Center to analyze African DNA. Their goal...
(Date:5/15/2008)... JOLLA, CA - Now that high school biology students...ranscribed into messenger RNA (mRNA), which is the... of molecules, sending studentsand many scientists...alk Institute for Biological Studies investigator ...online issue of Developmental Cell, shows that the...
(Date:5/15/2008)...shermen hold empirical knowledge that tuna aggrega...rope, pieces of wood, or even large marine mammals...egation behaviour, but the past 20 years have seen...he associated concentrations of fish. Fishermen ca...t as FADs. An enormous purse-seine net, deployed i...
Breaking Biology News(10 mins):Researchers document rapid, dramatic 'reverse evolution' in the threespine stickleback fish 2Researchers document rapid, dramatic 'reverse evolution' in the threespine stickleback fish 3Long lost sisters 2Plant biologists discover unexpected proteins affecting small RNAs 2Plant biologists discover unexpected proteins affecting small RNAs 3Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 3Environmental exodus 1331 1Environmental exodus 1331 2An intelligent new way to support the teaching of evolution 1328 1An intelligent new way to support the teaching of evolution 1328 2Novel MRI Technique Shows Secondhand Smoke Damages Lungs 6898 1Novel MRI Technique Shows Secondhand Smoke Damages Lungs 6898 2Novel MRI Technique Shows Secondhand Smoke Damages Lungs 6898 3CVS Caremark All Kids Can and Scholastic Distribute Free Educational Guides in Schools to Champion Acceptance and Build Self Esteem among Second Grade 6893 1CVS Caremark All Kids Can and Scholastic Distribute Free Educational Guides in Schools to Champion Acceptance and Build Self Esteem among Second Grade 6893 2CVS Caremark All Kids Can and Scholastic Distribute Free Educational Guides in Schools to Champion Acceptance and Build Self Esteem among Second Grade 6893 3
...ing infection in the body, a virus such as HIV inv...the cell,s outer membrane. Once inside the cell, t... turning the ,host, cell into a factory to produce... invade other cells in the body. , Scientists had ...l,s membrane, infection of the host cell was inevi...
...vermore National Laboratory (LLNL) and the Linnaeu...rsity in Sweden have developed a new bioinformatic...ns in DNA that help control gene activity. The coo...in the United States and by Jan Komorowski in Swed...sms that tell genes when to switch on and off is o...
...d a new phenomenon in which one bacterial cell can...he bacteria that stop growing may go into a dorman...ications for management of chronic diseases, such ...team of scientists working in the laboratory of Da... California, Santa Barbara, is reported in the Aug...
... for the first time have assessed dolphin and porp...ly threatened by entanglement in fishing gear and ... report commissioned by the World Wildlife Fund. T... bycatch that will most likely benefit from immedi...ntervention. , The list of dolphins and porpoises ...
Other Biology News:Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 2Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development 3New bioinformatics technique for systematically analyzing key regions in DNA that help control gene activity 2One bacteria stops another on contact 2Canada's first embryonic stem cell lines 2Canada's first embryonic stem cell lines 3
UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity.
UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity.
Luminex 100 IS System from Luminex Corporation
DEPC-treated Water is suitable for use with RNA. It is prepared by incubating with 0.1% diethylpyrocarbonate (DEPC) and then autoclaved to remove the DEPC.DNase/RNase-Free Distilled WaterDistilled Wa
Biology Products: